Charles M. Baum
2013
In 2013, Charles M. Baum earned a total compensation of $2.3M as President and Chief Executive Officer at Mirati Therapeutics, a 61% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $280,000 |
|---|---|
| Option Awards | $1,538,513 |
| Salary | $500,000 |
| Other | $5,194 |
| Total | $2,323,707 |
Baum received $1.5M in option awards, accounting for 66% of the total pay in 2013.
Baum also received $280K in non-equity incentive plan, $500K in salary and $5.2K in other compensation.
Rankings
In 2013, Charles M. Baum's compensation ranked 3,371st out of 12,286 executives tracked by ExecPay. In other words, Baum earned more than 72.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,371 out of 12,286 | 73rd |
Division Manufacturing | 1,141 out of 4,612 | 75th |
Major group Chemicals And Allied Products | 305 out of 1,462 | 79th |
Industry group Drugs | 209 out of 1,156 | 82nd |
Industry Pharmaceutical Preparations | 173 out of 890 | 81st |
Source: SEC filing on April 23, 2015.
Baum's colleagues
We found two more compensation records of executives who worked with Charles M. Baum at Mirati Therapeutics in 2013.